BEST OF ASCO
Live / Registered — Registered and renewed (as of 31 Jul 2024)
What this means for you
Registered since 01 Feb 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Feb 2025).
Record
- Serial number
- 76508969
- Registration number
- 2923905
- Mark type
- Word mark
- Filed
- 24 Apr 2003
- Published for opposition
- 13 Jan 2004
- Registered
- 01 Feb 2005
- Next maintenance due
- 01 Feb 2025
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 041 — Education and entertainment services: EDUCATIONAL SERVICES, NAMELY, CONDUCTING CLASSES, SEMINARS, CONFERENCES AND WORKSHOPS IN THE FIELD OF NEOPLASTIC DISEASES AND PROVIDING TRAINING IN THE PRACTICE OF CLINICAL RESEARCH AND MEDICAL CARE OF PATIENTS WITH NEOPLASTIC DISEASES AND PROVIDING COURSE MATERIALS IN CONNECTION THEREWITH
Owner
- American Society of Clinical Oncology, Inc., Alexandria, VA, US
- American Society of Clinical Oncology, The, Alexandria, VA, US
- American Society of Clinical Oncology, The, Alexandria, VA, US
Prior registrations
Prosecution history
- 31 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 31 Jul 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 31 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 May 2024 — TEAS SECTION 8 & 9 RECEIVED
- 01 Feb 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Sept 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Aug 2014 — TEAS SECTION 8 & 9 RECEIVED
- 27 Aug 2012 — CORRECTION UNDER SECTION 7 - PROCESSED
- 25 Aug 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Aug 2012 — TEAS SECTION 7 REQUEST RECEIVED
- 09 Feb 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.